Original Research
Accepted on 13 Nov 2024
Global lncRNA expression signature in pre-metastatic lung and their regulatory effects in pulmonary metastasis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1506561
Type at least 3 characters
6,666 articles
Articles
Original Research
Accepted on 13 Nov 2024
Integrative analysis of PANoptosis-related genes in diabetic retinopathy: machine learning identification and experimental validation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1486251
Original Research
Accepted on 13 Nov 2024
Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell lymphoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1481080
Review
Published on 13 Nov 2024
The role of miR-152 in urological tumors: potential biomarkers and therapeutic targets
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1464327
- 163 views
Original Research
Published on 13 Nov 2024
IGF2BP1 accelerates the aerobic glycolysis to boost its immune escape in hepatocellular carcinoma microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1480834
- 195 views
Review
Published on 13 Nov 2024
Logic-gated and contextual control of immunotherapy for solid tumors: contrasting multi-specific T cell engagers and CAR-T cell therapies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1490911
- 940 views
Original Research
Published on 13 Nov 2024
Advances in research on the relationship between mitochondrial function and colorectal cancer: a bibliometric study from 2013 to 2023
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1480596
- 238 views
Original Research
Published on 13 Nov 2024
Preclinical delayed toxicity studies of BCMA CAR T-cell injection in B-NDG mice with multiple myeloma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1435934
- 235 views
Clinical Trial
Published on 13 Nov 2024
SOX combined with tislelizumab and low-dose radiation therapy for the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase Ib/II clinical trial
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1431957
- 184 views
Review
Published on 13 Nov 2024
circFOXP1: a potential diagnostic and therapeutic target in human diseases
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1489378
- 192 views
Review
Published on 13 Nov 2024
Nanomaterials: breaking the bottleneck of breast cancer drug resistance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1492546
- 141 views
Review
Published on 13 Nov 2024
Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1418131
- 179 views
Correction
Published on 13 Nov 2024
Corrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1518823
- 104 views
Original Research
Published on 13 Nov 2024
Protective effects of YCHD on the autoimmune hepatitis mice model induced by Ad-CYP2D6 through modulating the Th1/Treg ratio and intestinal flora
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1488125
- 242 views
Original Research
Published on 13 Nov 2024
Comparison of treatment models for single primary advanced gallbladder cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1500091
- 192 views
Original Research
Published on 13 Nov 2024
A novel platelets-related gene signature for predicting prognosis, immune features and drug sensitivity in gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1477427
- 183 views